Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Prevalence, Risk Factors and Optimal Biopsy Protocol of Barrett's Esophagus in Taiwan - A Prospective Randomized Study

NCT05818072 is registered in ClinicalTrials.gov with E-DA Hospital as lead sponsor.

NCT NCT05818072
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05818072 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Prevalence, Risk Factors and Optimal Biopsy Protocol of Barrett's Esophagus in Taiwan - A Prospective Randomized Study
Lead sponsor
E-DA Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
March 13, 2023
Completion date
December 31, 2026
Enrollment
165 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

barrett's esophagus, intestinal metaplasia